A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol by Bower, P et al.
STUDY PROTOCOL Open Access
A cluster randomised controlled trial of the
clinical and cost-effectiveness of a ‘whole
systems’ model of self-management support for
the management of long- term conditions in
primary care: trial protocol
Peter Bower1, Anne Kennedy1*, David Reeves1, Anne Rogers1, Tom Blakeman1, Carolyn Chew-Graham1,
Robert Bowen1, Martin Eden1, Caroline Gardner1, Mark Hann1, Victoria Lee1, Rebecca Morris1, Joanne Protheroe2,
Gerry Richardson3, Caroline Sanders1, Angela Swallow1 and David Thompson4
Abstract
Background: Patients with long-term conditions are increasingly the focus of quality improvement activities in
health services to reduce the impact of these conditions on quality of life and to reduce the burden on care
utilisation. There is significant interest in the potential for self-management support to improve health and reduce
utilisation in these patient populations, but little consensus concerning the optimal model that would best provide
such support. We describe the implementation and evaluation of self-management support through an evidence-
based ‘whole systems’ model involving patient support, training for primary care teams, and service re-organisation,
all integrated into routine delivery within primary care.
Methods: The evaluation involves a large-scale, multi-site study of the implementation, effectiveness, and cost-
effectiveness of this model of self-management support using a cluster randomised controlled trial in patients with
three long-term conditions of diabetes, chronic obstructive pulmonary disease (COPD), and irritable bowel
syndrome (IBS). The outcome measures include healthcare utilisation and quality of life. We describe the methods
of the cluster randomised trial.
Discussion: If the ‘whole systems’ model proves effective and cost-effective, it will provide decision-makers with a
model for the delivery of self-management support for populations with long-term conditions that can be
implemented widely to maximise ‘reach’ across the wider patient population.
Trial registration number: ISRCTN: ISRCTN90940049
Introduction
Long-term conditions are increasingly important deter-
minants of quality of life and healthcare costs in popula-
tions worldwide [1]. There are major initiatives ongoing
to improve quality of care and achieve better health in
these populations [2]. Increasing healthcare costs
associated with an ageing population and growing
awareness of the links between behaviour and health
has meant that even greater focus has been placed on
self-management, defined as ‘the care taken by indivi-
duals towards their own health and well being: it com-
prises the actions they take to lead a healthy lifestyle; to
meet their social, emotional and psychological needs; to
care for their long-term condition; and to prevent
further illness or accidents’ [3]. Self-management has
the potential to improve population health without
incurring major cost increases. In the UK, the influential
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Wanless report suggested that the future costs of health-
care were very much dependent on ‘how well people
become fully engaged with their own health’ [4],
although others have suggested self-management poli-
cies are part of an ideological shift from patient rights
to individual responsibilities [5].
However, realising the potential of self-management
requires effective ways of encouraging appropriate beha-
viour change in patients and professionals. There are a
number of factors influencing self-management, includ-
ing patient factors (e.g., lay epidemiology and health
beliefs, self-efficacy, emotional responses to long-term
conditions, identity, and pre-existing adaptations), and
wider influences include the organisation of the health-
care system as well as access to material and community
resources [6]. A number of models of self-management
have been proposed in the literature, including increas-
ing access to health information [7] and deployment of
assistive technologies [8,9]. Patient skills training
(through the Chronic Disease Self-Management Pro-
gramme and its derivatives) is routinely used to encou-
rage patients to access and use group-based support to
enhance their individual self-management skills [10,11].
There is evidence for the effectiveness of the pro-
gramme on some outcomes [12], but there are signifi-
cant limitations. Intervention ‘reach’ is defined as the
‘percentage and risk characteristics of persons who
receive or are affected by a policy or program’ [13,14].
Interventions with limited ‘reach’ are unable to translate
the effectiveness of an intervention at the individual
level to that of the wider population. In the case of the
Chronic Disease Self-Management Programme, require-
ments for self-referral or referral from healthcare profes-
sionals means that levels of uptake can be low, and
biased towards certain patient groups, threatening reach
and equity [15,16].
Enhancing the ‘reach’ of self-management
Health policy in the United Kingdom (UK) has worked
with a model that organises care for long-term condi-
tions around three tiers: self-management support for
low risk patients; disease management for patients at
some risk; and case management for patients with mul-
tiple, complex conditions. In the UK, the bulk of disease
management is already delivered through primary care.
Primary care is generally defined in terms of attributes
such as a gatekeeping function and first contact care
[17], but other attributes also make it an excellent plat-
form for self-management support. Primary care offers
open access between the health service and the popula-
tion, can deliver continuity of care through an extended
personal relationship or through informational continu-
ity, and has a role in helping patients achieve care that
balances compliance with clinical guidelines and
consistency with patient needs and preferences. Deliver-
ing self-management support through primary care also
maximises ‘reach’, because in any one year most patients
with a long-term condition will consult their primary
care provider.
However, there are major barriers to achieving effec-
tive self-management support in primary care. Self-man-
agement is only one priority among many facing
primary care professionals [18], and there is evidence
that many primary care professionals do not see self-
management as a core part of their remit [19,20]. This
is especially true when incentives (financial and other-
wise) are focussed on specific clinical tasks and biomedi-
cal parameters [21]. Self-management has also been
associated with new social movements and patient
autonomy and activation and primary care may not
necessarily or automatically harness this potential [22].
Achieving the potential of primary care in delivering self-
management support
Research in quality improvement in healthcare has indi-
cated that, all other things being equal, multifaceted
interventions are more effective than simpler ones [23],
and that genuine and enduring change requires a multi-
level approach, where interventions at different levels
are interlinked and mutually reinforcing, in order to
maximize impact. Our research team has engaged in a
programme of research over a number of years that has
explored the barriers and facilitators to effective self-
management support. On the basis of this work, we
argue that self-management support requires:
1. A whole systems perspective that involves interven-
tions at the patient, practitioner, and service organisa-
tion levels in the delivery of self-management support.
Many self-management interventions have focussed on
patient behaviour change or professional training only,
but we argue that each level has a different function in
encouraging and supporting self-management behaviour,
and that effects are maximised when interventions occur
at all levels and include attention to patient actions out-
side the context of contacts with the health service [24].
2. Widening the evidence base to acknowledge a range
of disciplinary perspectives on the way in which patients
and professionals respond to and manage their long-
term conditions. Although psychology has dominated
the design of many interventions for self-management
support through models such as self efficacy theory [10],
there are a wide range of applied social science theories
that can inform an understanding of the way that
patients and professionals understand, respond to, and
manage long-term conditions [25,26].
The Whole System Informing Self-Management
Engagement (WISE) ‘whole systems’ model of self-man-
agement support has been designed to reflect these
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findings and provide a feasible and effective model of
self-management support [27]. The model aims to sup-
port patients to receive guidance from trained practi-
tioners working within a healthcare system geared up to
be responsive to patient need. As a self-management
research group in the National Primary Care Research
and Development Centre, we developed the whole sys-
tems approach over a number of years as a response to
the question, ‘what can the NHS do to support self-
management?’ [28]. The whole systems approach had its
roots in policy direction and analysis that was focussed
on system elements, access, and patients, as well as pro-
fessionals who inspired the direct transfer into self-man-
agement [29,30]. The current paper describes the model
and a protocol for the evaluation of its implementation
within a health system through a large-scale pragmatic
cluster randomised controlled trial (RCT). Our approach
follows the phased development and evaluation frame-
work outlined for complex interventions by the Medical
Research Council [31]. We have developed an evidence
base for the elements of the WISE approach using
mixed methodology; a combination of RCTs, nested
qualitative studies and economic evaluation. In sum-
mary, the evidence shows that:
1. Information can be effectively improved to incor-
porate patient experience and expertise alongside med-
ical information about management and treatment
[32-36].
2. Clinician training in patient-centred consultation
skills and shared decision-making with patients to guide
and support self-management is acceptable and appro-
priate and leads to positive outcomes [37-40].
3. Health services systems that are better aligned to
patient practices of self-management are generally well
received [41,42].
The WISE intervention as described in this protocol is
a culmination of the findings and learning from this
body of work; we have made modifications according to
the evidence, e.g., our findings on the limits to patient
centredness [43], and we have adapted the clinical train-
ing element so that it can be delivered to a primary care
team, and this has been previously evaluated in an
exploratory study [44]. The study is a pragmatic cluster
RCT using a wait list control (Figure 1). The interven-
tion is designed to impact on all primary care staff in a
practice, thus randomisation is at the level of the prac-
tice to avoid contamination. However, the aim of the
study is to improve outcomes at the level of the indivi-
dual patient.
Methods
The trial is a pragmatic, two-arm, practice-level cluster
RCT evaluating outcomes and costs associated with the
WISE ‘whole systems’ model.
The principal research question is: Does the adoption
of the WISE ‘whole systems’ model of self-management
support in primary care lead to improved health out-
comes and cost-effective management of patients with
long-term conditions, compared to routine primary
care?
Population
The general practice is the cluster in the trial, and we
aim to involve all practices in a local ‘health economy’
in the UK. The context is a primary care organisation (a
Primary Care Trust) in Salford, in the North West of
England. The organisation has a strong commitment to
supporting self-management, viewing this as part of a
strategic approach to improving the health and well-
being of the population. Many factors related to living
in Salford may lead to poor health:
’Life expectancy for people who live in Salford is less
than in the rest of England and Wales. Salford’s men
die on average three years earlier and women die
just less than three years earlier, compared with the
national average. The reasons for this are varied and
include social factors, such as high deprivation rates,
high unemployment and a reliance on social housing
in particular areas.’ [45]
We aim to recruit patients with three long-term con-
ditions: diabetes; chronic obstructive pulmonary disease
(COPD) and irritable bowel syndrome (IBS). The WISE
‘whole systems’ model is designed to be robust and
adaptable enough to use with the vast majority of
patients with a long-term condition. The particular con-
ditions to be included in the trial have been chosen on
the basis of a number of theoretical, policy, and practical
criteria, and they have important similarities and differ-
ences. Each condition is amenable to self-management
interventions [40,46,47], and there is already a signifi-
cant evidence base that will facilitate comparison of the
effects of the WISE ‘whole systems’ model with alterna-
tives (such as individual patient education and the
Chronic Disease Self-Management Programme). The
conditions are also of sufficiently high prevalence within
practices to meet the sample size needs of the proposed
trial. UK health policy has identified the need to reduce
health inequalities [48], and local data suggest that the
prevalence of COPD increases with deprivation.
The conditions also have important differences in
symptoms, experience, and management. IBS is a more
‘contested’ condition with greater disagreement about
diagnosis and appropriate management. The manage-
ment of both diabetes and COPD are also incentivised
in the UK under the Quality and Outcomes Framework
[49], whereas IBS is not.
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As a pragmatic trial of a model of service delivery, the
inclusion criteria are simple and broad to enhance the
external validity of the study. Patients must have a clini-
cal diagnosis of COPD, diabetes, or IBS, identified from
existing primary care systems using appropriate clinical
registers (for COPD and diabetes) and Read codes (for
IBS) and verified by the primary care professionals.
Patients must also demonstrate sufficient English to be
able to complete questionnaires; and there must be
agreement from the practice that the patient is
appropriate for research assessment. Exclusion criteria
include patients in the palliative care stage of condition
or the presence of mental health problems that reduce
capacity to consent and participate.
Patients who have two or more of our index condi-
tions, or a single index condition and another long-
term condition are still included in the trial. Where a
patient is identified as having two or more of the three
trial conditions, clinical staff in the practice will be
asked to determine which the main condition is, in
Recruitment of practice pair 
Randomisation of practice pair 
Identification of existing COPD, 
diabetes and IBS patients  
Baseline assessment of existing 
patients  
Intervention group 
Training of practice 
6 and 12 month 
assessments  
Usual care 
Training of practice 
Delivery of WISE to 
existing patients 
6 and 12 month 
assessments  
Figure 1 Study flowchart (original design-see discussion).
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order to assist with appropriate outcome measurement
(see below).
Interventions
The intervention is designed to impact on the patient,
professional, and system levels (see Figure 2). The pri-
mary target of the intervention is the cluster (practice),
and the overall aim of the intervention is to encourage
practices to adopt a structured and patient-centred
approach to the routine management of long-term con-
ditions through providing skills, resources, and motiva-
tion to make changes to service delivery in line with the
principles of the WISE ‘whole systems’ model (see Fig-
ure 3). The development and evaluation of the training
intervention have taken place prior to this trial, and
details of the theoretical background and content have
been published elsewhere [44]. The planned approach to
training combines evidence-based approaches to chan-
ging professional behaviour with approaches to ‘normal-
ise’ those behaviours in current practice. The
intervention involves the whole practice, and there are
also ‘system’ links to the local health organisation (the
Primary Care Trust), which provides access to additional
resources, including a dedicated website of local self-
management support.
Practice-based training seeks to teach three core skills
to primary care staff (see Figure 4):
1. Assessment of the individual patient’s self-manage-
ment support needs, in terms of their current capabil-
ities and current illness trajectory.
2. Shared decision making about the appropriate type
of self-management support based on that assessment
(e.g., support from primary care, written information
sources, long-term condition support groups or condi-
tion-specific education), facilitated by the PRISMS tool
[50].
3. Facilitating patient access to support. This may
involve signposting patients to various resources
depending upon the outcomes of the assessment and
shared decision-making processes. These may include
 Patient Professional Systems 
Strategy Make better use of self care support 
Provide better self care 
support 
Improve access to self care 
support 
 
  
 
Specific 
method 
Find best option for self 
care support based on: 
 Current ability and 
needs 
 Personal goals and 
priorities 
 A negotiated plan 
Training in 
 Assessing patient’s 
skills, beliefs and 
values 
 Shared decision 
making 
 Helping patients get 
access to appropriate 
self care support 
 Access to training for 
staff 
 Access to computer 
support tools 
 Regular update of local 
support options  
 Ensure patients have 
easy access to support 
options 
 Awareness of barriers to 
access in the practice 
Tools  PRISMS 
 Menu of options 
 Management plan 
 Computer template 
 PRISMS 
 Explanatory model 
 Menu of options 
 Management plan 
 Computer template for 
support tools 
 Menu of options 
 Self care support 
directory of local groups 
and organisations 
Figure 2 Outline of the WISE whole systems model.
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access to the Expert Patients Programme (the UK ver-
sion of the Chronic Disease Self-Management Pro-
gramme), disease specific courses (such as pulmonary
rehabilitation classes), or generic support such as
befriending. The training encompasses ways health pro-
fessionals can negotiate with patients about more appro-
priate utilisation of health service resources. In the case
of IBS, this may also involve referral to psychological
treatment services (cognitive behavioural therapy and
hypnotherapy) for eligible patients (so-called ‘stepped-up
care’). Patients with IBS are informed of the possibility
of referral to such services through information leaflets.
As part of the training, primary care professionals
receive specific assistance in development of the core
WISE skills, followed by integration of techniques
through role-play, and individualised performance
feedback based on that role-play [51,52]. The interven-
tion is delivered over two sessions with an intermedi-
ary session to discuss progress and involves all relevant
staff within the practices for the first session (including
general practitioners (GPs), nurses, practice managers,
and reception staff) and clinical staff for the second
session (Figure 5). A training manual is given to all
those who participate in the training for use within the
training session and to support practice. The training
was piloted and modified on the basis of a pilot [44].
The intervention is conducted by trained facilitators
working alongside the research team rather than the
research team itself, to test a model of delivery that
would be feasible in routine practice and wider
implementation.
Outcomes
All outcomes are at the level of the individual patient.
Each practice sends eligible patients a questionnaire at
baseline, to be returned directly to the research team.
Follow-up questionnaires are sent at 6 and 12 months.
The primary endpoint will be the 12-month follow-up
of patient health outcomes and costs. The trial has
three primary outcomes based on patient-reported
measures: shared decision-making with GPs; self-effi-
cacy; and generic health-related quality of life (Addi-
tional file 1). These represent core measures along the
‘causal pathway’ from intervention to health outcomes.
The study will also collect a number of secondary out-
comes, including disease-specific quality of life, self-
management behaviours, service utilisation, empower-
ment, general health, social/role limitations, well-
being, and vitality (Additional file 1). There is no
blinding of patients or outcome assessors, although all
outcomes are self-report. The analyst remains blind to
allocation.
Assessment 
 
 
 
Shared 
decision 
making using 
PRISMS tool 
Accessing 
resources 
Web based 
information 
 
 
 
EPP 
 
 
 
 
Information 
sources and 
guidebooks 
 
 
Voluntary 
sector 
 
 
Stepped up 
care* 
 
 
 
Feedback 
and ongoing 
care 
* Stepped up care’ refers to the provision of psychological therapies (CBT and hypnotherapy), which are part of the study protocol for the management of IBS patients only 
Figure 3 Process of care in the WISE model.
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Design
The study is a pragmatic cluster RCT using a wait list
control (Figure 1). The intervention is designed to
impact on all primary care staff in a practice, thus ran-
domisation is at the level of the practice to avoid
contamination.
Practice recruitment and randomisation
Practices are recruited via practice visits and asked to
identify their preferred time during the year for training.
Practices are paired as closely as possible according to
their preferred times, and using a minimisation proce-
dure, one practice in each pair allocated to training in
the first year, with the other practice allocated to train-
ing at the same time the following year. Research staff
recruiting practices are unaware of the next allocation
in the sequence at the time of recruitment. Baseline
(and subsequent follow-up) data collection then takes
place at both practices in a pair at the same time. This
ensures a balance between the intervention and control
groups, thus avoiding potential bias from changes to
care delivery outside the trial context (e.g., new
Training 
needs 
Collaborative 
tasks 
Knowledge Attitudes 
 
Skills Tools 
A
SS
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M
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T 
SH
A
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D
 D
E
CI
SI
O
N
 M
A
K
IN
G
 
FA
CI
LI
TA
TI
N
G
 A
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E
SS
 
Explore 
Problems 
What is an illness 
trajectory? 
 
 
 
 
 
 
 
How can patients 
be assessed in 
terms of self-
management 
progress? 
 
Value patient 
individuality and 
variability 
 
 
 
 
Explore reasons for visit 
 
Explore progress  
(acknowledge patient’s 
current strategies and 
prior experiences) 
 
Explore ideas, concerns, 
expectations and  
attitudes                   
PRISMS  
Establish 
Priorities 
 
 
Value patient 
involvement 
 
 
Identify key problems/ 
issues to be addressed        
 
  
PRISMS 
linking to 
Explanatory 
Model 
 
Make Sense 
of Problems 
 Connect problems 
 
Check understanding 
 
Consider behavioural 
change 
 
Identify what is 
achievable 
 
Explanatory 
Model 
Share the 
Process of 
Decision 
Making 
What is the 
evidence base 
about involving 
patients in 
decision making?   
 
 
Do you have 
knowledge of 
resources 
available in the 
practice, wider 
community and 
internet? 
Value importance 
of patient 
increasing 
knowledge,          
extending 
experience,    & 
gaining support 
 
Explore genuine options 
for achieving priorities 
 
Provide information 
about options 
 
Clarify patient values 
(pros and cons), highlight 
discrepancies   
 
Menu of Options 
 
Negotiate a 
Plan of 
Action 
 Agree what patient and 
professional are going to 
do  
 
Summarise and rehearse 
 
Safety net  
 
Plan of Action 
 
Negotiate 
Follow up 
 
 Negotiate and establish a 
plan for follow up  
Plan of Action 
Figure 4 Collaborative tasks, knowledge, attitudes, skills and support tools in WISE.
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government policy or local system changes on the man-
agement of long-term conditions).
The practice (cluster) pairs are allocated–one to the
intervention group and the other to the control–using a
minimisation algorithm by the trial statistician. Minimi-
sation variables are practice size, practice deprivation
(measured by the Index of Multiple Deprivation), and
practice contractual arrangements (i.e., general medical
services or personal medical services). This ensures that,
barring attrition, the two arms of the trial will have
equal numbers of practices and be balanced on the
minimisation variables and data collection timeline.
After practice pairing and allocation, potentially eligible
patients at each intervention and control group practice
are identified from the computer systems and checked
for eligibility to be contacted by practice clinical staff.
Sample size
Sample size calculations have been made on the basis of
data collected from the national evaluation of the Expert
Patients Programme [11]. Although all three patients
groups will be combined in the primary analysis (see
below), we have powered the trial to detect a fairly
small effect of the intervention on diabetes, COPD, and
IBS separately.
Data on outcomes from the national evaluation of the
Expert Patients Programme had a range of intraclass
correlation coefficients (ICCs) from 0.01 to 0.07. For the
power calculations, we assume an ICC of 0.05. Baseline-
follow up correlations are taken to be 0.6, towards the
lower end of those found in the Expert Patients Pro-
gramme. On these assumptions, each arm of the trial
requires 18 practices, and 36 patients per condition per
Session 1 
The first session is delivered to the whole practice by two trainers employed by the PCT and 
familiar with primary care and involves clinicians, the practice manager, and administrative 
staff. The first session has the following structure: 
 Brief introduction to WISE 
 Team building exercise 
 Exercise on care pathways for patients with long-term condition. 
 WISE tools—PRISMS [50], explanatory models, and menu of local support 
 Interactive discussion 
 Nomination of practice member to lead on implementation 
Intermediate meeting 
This session is a short meeting between the trainers and the nominated practice lead to discuss 
progress with the WISE approach since session 1. 
Session 2 
This session is delivered by two trainers to all clinicians in the practice team. Through the use 
of role play and clinical discussion, the training focuses on embedding the three core skills, 
assessment of self-management needs and capabilities; shared decision making; and facilitating 
patient access to support into primary care consultations. Figure 4 outlines the collaborative 
tasks, knowledge, attitudes, skills, and support tools relevant to these core training needs. The 
session has the following structure: 
• Introduction & provision of manual   
• Reflection of competencies  
 Demonstration of skills to support self-management  
• Skills practice 
• Discussion on how to ensure sustainability of WISE  
Figure 5 Training sessions.
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practice, to achieve 80% power to detect an effect size of
0.21 per condition. To allow for attrition of practices
(estimated to be around 10%), we aim to recruit 20
practices into each arm of the trial. Questionnaires will
be sent to 80 patients per practice with each condition.
For each of the three conditions, this should provide on
average 48 patients per practice at baseline, reducing to
36 patients at 12 months. Smaller practices may not
have 80 patients with COPD, in which case we will
compensate by recruiting additional patients from larger
practices. On the basis of the above, we aim to recruit
totals of 1,728 diabetic, 1,728 COPD, and 1,728 IBS
patients.
The trial is still ongoing, but we present our baseline
sample in Figure 6.
Training procedure
Intervention practices will receive training as soon as
possible after baseline data collection and subsequent
trial arm allocation; control practices will receive train-
ing one year later. Training will be undertaken in two
sessions, with the second session approximately one
month after the first.
Analysis
An a priori analysis plan–laying down full details of the
primary and secondary outcomes, covariates, treatment
of missing values, other methods, and sensitivity ana-
lyses–will be drawn up prior to analysis of the RCT.
Each outcome will be subjected to analysis of covar-
iance within a multilevel multivariate regression frame-
work, following intention-to-treat principles and with
the analyst blind to practice allocation to trial arms. A
two-level mixed model will be used to account for the
clustering of patients within practices and for variation
between practice means. The primary analysis will test
for an intervention effect across all three condition
groups combined, adjusted for any main effects of con-
dition on outcome and controlled for baseline values of
the outcome and the design factors (practice list size,
Index of Multiple Deprivation (IMD), and type of con-
tract). Although practices are randomised in pairs, the
pairing is purely to balance the groups with respect to
the data collection timeline, and practice pairs can vary
in all other respects. Consequently, the pairing will not
be a covariate in the analysis.
A secondary analysis adding in an interaction term
between treatment group and condition will be con-
ducted to determine if the intervention effect differs by
condition. If the interaction is statistically significant,
condition-specific effect sizes and associated 95% confi-
dence intervals will be derived. Additional secondary
analyses will be undertaken to examine the impact of
the intervention on quality of life within each of the
three target condition groups, as measured by each of
the condition-specific instruments (Additional file 1).
Sensitivity analyses will be undertaken to assess the
stability of the results to the model specification. In par-
ticular, to patient and practice covariates found to be
not fully balanced across the two trial arms, to the treat-
ment of missing values, and to normality assumptions
where outcomes demonstrate non-normal distributions.
The trial will include an economic analysis to compare
the costs and outcomes for the trial arms. Cost-effec-
tiveness analysis will be used to estimate the incremen-
tal costs and quality adjusted life years (QALYs).
Appropriate sensitivity analysis will be used to assess
the robustness of results to changes in key parameters.
Discounting will be conducted as appropriate. This ana-
lysis will be to determine whether WISE provides a
cost-effective use of resources when compared with cur-
rent alternatives. This will be a ‘within trial’ cost-
Randomisation 
Intervention practices 
(n=22) 
Control practices 
(n=22) 
Diabetes 
 (n=1486) 
COPD  
(n=1016) 
IBS  
(n=809) 
COPD 
 (n=625) 
Diabetes  
(n=1063) 
IBS  
(n=611) 
Figure 6 CONSORT diagrams (baseline data only).
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effectiveness analysis where the costs and effects of the
WISE intervention over the time period of the trial will
be compared with usual care comparators described
above.
We will use a modification of the service utilisation
questionnaire successfully developed by us for our
national evaluation of the Expert Patients Programme
[53] that measures primary healthcare (GP visits, prac-
tise nurse visits), community health and social care, sec-
ondary healthcare services, out-of-pocket costs, and
costs of lost productivity. Unit cost estimates will then
be applied to these data to generate patient-level cost
estimates. The sources of unit costs will include routine
or published literature such as Personal Social Services
Research Unit Costs of Health and Social Care [54].
Patient-level costs will be appropriately discounted. A
GP cost per minute will be derived, and a cost per con-
sultation for each group will be estimated.
For the economic analysis, our measure of effective-
ness is the QALY, a composite measure of health com-
bining the quantity and quality of life [55]. QALYs will
be generated using the EQ-5D instrument that will be
collected via patient questionnaire at each follow up
point [56]. QALYs will be estimated for each patient by
weighting their survival time using the EQ-5D weights
[56]. The mean difference in costs and effect between
the treatment options will provide an informative incre-
mental cost effectiveness ratio. However, economic eva-
luation is conducted under conditions of uncertainty.
Parameter imprecision will be included in the analysis
using probabilistic sensitivity analysis based on Monte
Carlo simulation [57]. The results of the simulations will
illustrate the uncertainty in the data and will be repre-
sented using cost effectiveness acceptability curves
(CEACs) [58,59]. Given the data from the trial, the
CEAC will plot the probability of the WISE intervention
being more cost effective than usual care for a range of
threshold values of an additional QALY.
Wider process evaluation
A process evaluation has been designed to complement
and provide additional information concerning the trial.
Details about the process evaluation and accompanying
qualitative study are included in Additional files 2 and 3.
Discussion
The proposed study is an ambitious project that is
designed to provide a pragmatic, yet rigorous assessment
of the benefits of a whole systems approach to the deliv-
ery of self-management support in primary care.
The size and complexity of the proposed evaluation
means that it is extremely challenging to implement,
and initial delivery of the intervention and research
components has faced a number of barriers that has led
to a number of minor changes to the protocol. We
detail these changes and their potential threats to inter-
nal and external validity below.
Single health economy
Our aim was to deliver the proposed intervention across
all practices in a single primary care organisation to
assess an intervention effect across a complete health
economy. Although we were able to recruit 32 practices
in Salford (73% response rate), this did not give us the
desired level of statistical power. We therefore spread
our recruitment to a neighbouring Primary Care Trust
(Bury). This area has a similar socio-economic profile,
and the overall spread of IMD scores across practices is
quite similar to Salford (4.5 to 65.5, compared to 6.6 to
77.2). In addition, the two Trusts shared the same chief
executive and both are part of a North West self-man-
agement initiative. However, some aspects of the whole
systems intervention detailed previously were not avail-
able (such as existence of a dedicated self-management
education team and availability of certain community-
based support schemes). Differences in the financial
arrangements between Trusts also meant that we were
unable to offer control group practices in Bury PCT the
intervention after 12 months.
Selection of patients before practice allocation
One of the threats to the validity of a cluster rando-
mised trial is recruitment bias, where professionals allo-
cated to different trial arms recruit differently depending
on their allocation, leading to selection bias and baseline
incomparability [60]. It is preferable in these cases to
recruit patients prior to allocation. Although this was
our intention, in the event we found that practices
required adequate advance notice of their training date,
hence it became necessary to inform them of their
group allocation prior to patient selection. This does
raise the possibility of bias, but we are confident that
such bias will be small. Initial patient selection was via
existing disease registers and Read codes; therefore, the
only way practices could influence recruitment was to
request exclusion of a patient after they had been identi-
fied through these methods. These exclusions repre-
sented a relatively small proportion of patients (11%
control and 15% intervention with COPD, 10% and 11%
respectively for diabetes, and 18% and 11% respectively
for IBS).
Baseline sampling and assessment
Response rates from patients at the practices first to
enter the trial were considerably lower than originally
anticipated. In view of this, we made a number of
adjustments to improve response. To ensure the patient
numbers required for our target level of statistical
Bower et al. Implementation Science 2012, 7:7
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power, we increased the number of patients surveyed to
include all eligible patients at each practice, up to a
maximum of 200 per condition (selected at random
where this applied). Very few practices had more than
200 patients for any condition, hence the study became,
in effect, a total population survey.
We also introduced a financial incentive to patients
for returning a completed questionnaire. There is some
evidence that questionnaire length is a determinant of
response rates [61], and we took the decision to change
the baseline questionnaire to focus on a smaller number
of core variables (see Additional file 1). The main effect
on the trial of the shortened baseline questionnaire is to
reduce our scope for analysis of baseline moderators of
treatment effect. However, such analyses are always sec-
ondary to the primary intention-to-treat analysis.
Additional material
Additional file 1: Outcome measures. Details of the outcome
measures used in the trial [62-85].
Additional file 2: Process Evaluation. Outline of the process evaluation
[86,87].
Additional file 3: A qualitative study of the role of patients’ social
networks for long-term condition management in primary care.
Outline of the qualitative study [88-90].
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